Latest

COVID-19

·January 17, 2024·5 min read

COVID-19 May Infect Dopamine Neurons

A new study reveals that SARS-CoV-2 can infect dopamine neurons, potentially linking to long COVID symptoms like brain fog and depression. The research shows that these neurons enter a state of senescence, ceasing to function and causing inflammation. This discovery was unexpected, as the study initially aimed to understand how different cell types respond to the virus, but found this unique pathway only in dopamine neurons.

Featured Genetics Neuroscience

·January 3, 2024·6 min read

High-Fat Diets Impact Health, Immunity, and COVID-19 Risk

A new study highlights the effects of high-fat diets on genes associated with obesity, colon cancer, immune function, brain health, and potentially COVID-19 risk. Researchers fed mice three different high-fat diets and observed changes in gene expression, gut bacteria, and susceptibility to infectious diseases.

Featured Genetics Neurology Neuroscience

·December 15, 2023·5 min read

Alzheimer’s Alters COVID-19 Response in Olfactory Cells

Researchers uncovered how Alzheimer's Disease (AD) impacts COVID-19 outcomes through changes in the olfactory mucosal cells. Their study focused on individuals with AD who experienced exacerbated COVID-19 symptoms.

Featured Neurology Neuroscience

·December 11, 2023·7 min read

MRI Reveals Lasting Brain Changes in Post-COVID Patients

Researchers discovered structural differences in the brain white matter of COVID-19 patients with persisting symptoms, using advanced diffusion MRI technology. This study compares 16 men who had severe COVID-19 with healthy individuals, revealing that these differences might explain neurological problems post-COVID.

Featured Neurology Neuroscience

·November 24, 2023·4 min read

New Treatment for COVID-Induced Smell Loss

A new study presents a promising treatment for restoring the sense of smell in long-COVID patients. The study explores the effectiveness of CT-guided stellate ganglion block, a minimally invasive procedure, in treating parosmia—a condition affecting up to 60% of COVID-19 patients where the sense of smell is distorted.

Featured Neuroscience

·November 24, 2023·4 min read

How Human Actions Alter COVID-19 Evolution

A research group using AI and mathematical modeling has discovered that human behavioral responses to COVID-19, like lockdowns and isolation, influence the evolution of the virus. Their study found that SARS-CoV-2 variants became more transmissible early in infection due to these human interventions.

Featured Neurology Neuroscience

·November 22, 2023·4 min read

Long COVID’s Unique Neural Impact

A new study reveals distinct brain changes in long COVID patients compared to those fully recovered from COVID-19 and healthy controls. The research employed Diffusion Microstructure Imaging (DMI) to analyze brain microstructures in 89 long COVID patients, 38 recovered COVID-19 patients, and 46 healthy individuals.

Featured Neurology Neuroscience

·November 3, 2023·4 min read

History of Childhood Adversity Tied to Higher COVID-19 Mortality Risks

A recent study reveals that individuals who experienced childhood adversity, such as neglect or abuse, faced higher chances of COVID-19 hospitalization or mortality in adulthood. Analyzing over 151,200 adults from the UK Biobank, researchers linked increased reports of early life adversity to 12-25% elevated odds of severe COVID-19 outcomes.

Featured Neurology Neuroscience

·September 25, 2023·5 min read

Blood Biomarkers Highlight Immune Disruption in Long-COVID

Researchers reveal distinctive blood biomarkers in long COVID patients. This groundbreaking study establishes clear differences in immune and hormone function between individuals with long COVID and those without.

Featured Neurology Neuroscience

·September 19, 2023·6 min read

Is Early Convalescent Plasma Treatment A Barrier to Long COVID?

Researchers found that early treatment with plasma from recovered COVID-19 patients reduces the risk of developing post-COVID conditions or "long COVID." The study revealed that patients who received the plasma, rich in SARS-CoV-2 antibodies, had a reduced hospitalization rate and fewer long COVID symptoms compared to those receiving a placebo.

Featured Neurology Neuroscience

·September 4, 2023·5 min read

MIS-C and COVID-19: Unmasking Hidden Neurological Aftershocks in Kids

Children who suffered from MIS-C, post-COVID-19 exposure, might face long-term neurologic and psychosocial challenges. Researchers found that these children had a higher rate of neurological abnormalities and experienced conditions such as impaired memory, anxiety, and even ADHD.

This shows a woman with her head covered in fog.

Featured Neurology Neuroscience

·September 2, 2023·3 min read

Blood Clues to Long-COVID Brain Fog Discovered

Researchers have discovered two blood biomarkers that could predict cognitive deficits, including "brain fog," up to a year after a COVID-19 diagnosis. The study analyzed data from over 1,800 hospitalized patients and identified high levels of fibrinogen and d-dimer, proteins linked to blood coagulation, as being highly correlated with cognitive issues.

1 2 3 4 5 6 … 41

COVID-19

COVID-19 May Infect Dopamine Neurons

High-Fat Diets Impact Health, Immunity, and COVID-19 Risk

Alzheimer’s Alters COVID-19 Response in Olfactory Cells

MRI Reveals Lasting Brain Changes in Post-COVID Patients

New Treatment for COVID-Induced Smell Loss

How Human Actions Alter COVID-19 Evolution

Long COVID’s Unique Neural Impact

History of Childhood Adversity Tied to Higher COVID-19 Mortality Risks

Blood Biomarkers Highlight Immune Disruption in Long-COVID

Is Early Convalescent Plasma Treatment A Barrier to Long COVID?

MIS-C and COVID-19: Unmasking Hidden Neurological Aftershocks in Kids

Blood Clues to Long-COVID Brain Fog Discovered

AI Body Gap: Why Robots Need “Internal Feelings” to be Safe

Wetware AI: Living Brain Cells Trained to Run Chaos Math

Mapping the Brain’s Internal Stopwatch

Individual Cone Cells Create Our Sharpest Sight

Subscribe